Efficacy and safety of anti-PD-1/PD-L1-based dual immunotherapies versus PD-1/PD-L1 inhibitor alone in patients with advanced solid tumor: a systematic review and meta-analysis
Article in Cancer Immunology, Immunotherapy (June 2024)
The most recent citing publications are shown below. View all 315 publications that cite this research output on Dimensions.
Article in Cancer Immunology, Immunotherapy (June 2024)
Article in Journal of Materials Chemistry B (May 2024)
Article in PLOS Computational Biology (March 2024)